Literature DB >> 4610058

A new method for the preparation of EAC14 cell with human or guinea-pig serum.

K Nagaki, K Iida, S Inai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4610058     DOI： 10.1016/0022-1759(74)90117-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN： 0022-1759            Impact factor:   2.303


× No keyword cloud information.
  12 in total

1.  Differences between plasma and serum complement in patients with chronic liver disease.

Authors:  S Inai; H Kitamura; T Fujita; J Kojima; K Nagaki
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

2.  Studies of four Japanese families with hereditary angioneurotic edema: simultaneous activation of plasma protease systems and exogenous triggering stimuli.

Authors:  J Kodama; K Uchida; S Yoshimura; Y Katayama; H Kushiro; C Yutani; S Funahashi; O Takamiya; Y Matsumoto; Y Ando
Journal:  Blut       Date:  1984-11

3.  A complete selective C1q deficiency in a patient with discoid lupus erythematosus (DLE).

Authors:  A Uenaka; T Akimoto; T Aoki; I Tsuyuguchi; K Nagaki
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

4.  C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.

Authors:  Y Tanuma; H Ohi; S Watanabe; M Seki; M Hatano
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

5.  Monoclonal anti-human C3d antibodies: stabilization of the alternative pathway C3 convertase.

Authors:  Y Tanuma; H Ohi; M Hatano
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

6.  Compstatin analog Cp40 inhibits complement dysregulation in vitro in C3 glomerulopathy.

Authors:  Yuzhou Zhang; Dingwu Shao; Daniel Ricklin; Brieanna M Hilkin; Carla M Nester; John D Lambris; Richard J H Smith
Journal:  Immunobiology       Date:  2015-05-05       Impact factor: 3.144

7.  Occurrence of C3 nephritic factor and C4 nephritic factor in membranoproliferative glomerulonephritis (MPGN).

Authors:  H Ohi; T Yasugi
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

8.  Activation of complement in normal serum by hydrogen peroxide and hydrogen peroxide-related oxygen radicals produced by activated neutrophils.

Authors:  M Shingu; S Nonaka; H Nishimukai; M Nobunaga; H Kitamura; K Tomo-Oka
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

9.  Genetic polymorphism of the complement C2 in Japanese.

Authors:  K Tokunaga; C Araki; T Juji; K Omoto
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

10.  Significance of C3 nephritic factor (C3NeF) in non-hypocomplementaemic serum with membranoproliferative glomerulonephritis (MPGN).

Authors:  H Ohi; S Watanabe; T Fujita; T Yasugi
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.